Expert Review Of Drug Patent Applications: Improving Health In The Developing World

18 Aug 2009
View Resource

Engaging outside experts in patent review could curtail the granting of unmerited patents, which can lead to high prices for essential drugs in resource-poor countries.

Learn more about how you can help build a more equitable system for all